scispace - formally typeset
M

Markus B. Skrifvars

Researcher at University of Helsinki

Publications -  237
Citations -  6980

Markus B. Skrifvars is an academic researcher from University of Helsinki. The author has contributed to research in topics: Intensive care & Cardiopulmonary resuscitation. The author has an hindex of 37, co-authored 196 publications receiving 5206 citations. Previous affiliations of Markus B. Skrifvars include Helsinki University Central Hospital & Monash University.

Papers
More filters
Journal ArticleDOI

European Resuscitation Council Guidelines for Resuscitation 2015: Section 3. Adult advanced life support.

TL;DR: Anaesthesia and Intensive Care Medicine, Southmead Hospital, Bristol, UK Anaesthesia and intensive care Medicine, Royal United Hospital, Bath, UK School of Clinical Sciences, University of Bristol, United Kingdom, UK Department of Anesthesiology, and intensive care medicine, The National Institute for Mental Health (NIMH), London, UK NHS Foundation Trust, Coventry, UK The National Health Service (NHS), Coventry and Birmingham, UK Heart of England (HSE), Birmingham, Birmingham and The Royal National Institute of Neurological and Women's Health Service
Journal ArticleDOI

Therapeutic hypothermia utilization among physicians after resuscitation from cardiac arrest

TL;DR: Physician utilization of cooling after cardiac arrest remains low, and the data suggest that development of better cooling methodology and recent incorporation into resuscitation guidelines may improve use.
Journal ArticleDOI

Severe traumatic brain injury: targeted management in the intensive care unit

TL;DR: Progress in monitoring and in understanding pathophysiological mechanisms of TBI could change current management in the intensive care unit, enabling targeted interventions that could ultimately improve outcomes.
Journal ArticleDOI

Strict versus moderate glucose control after resuscitation from ventricular fibrillation

TL;DR: It is found that there is no additional survival benefit from strict glucose control compared with moderate glucose control with a target between 6 and 8 mmol/l in OHCA patients.